Aurora Cannabis (ACB) Depreciation & Amortization (CF) (2017 - 2025)
Aurora Cannabis (ACB) reported Depreciation & Amortization (CF) of $4.1 million for Q1 2025, down 44.51% year-over-year from $7.3 million in Q1 2024, and up 7.17% quarter-over-quarter from $3.8 million in Q4 2024.
Aurora Cannabis (ACB) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $4.1 million in Q1 2025.
- Depreciation & Amortization (CF) for Q1 2025 came in at $4.1 million, down 44.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.1 million (down 78.62% YoY), and the FY2025 annual result was $2.6 million, down 6.09% from the prior year.
- Depreciation & Amortization (CF) grew to $4.1 million in Q1 2025 per ACB's latest filing, from $3.8 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $24.6 million in Q2 2021 and troughed at $3.8 million in Q3 2024.
- A 5-year average of $8.5 million and a median of $7.2 million in 2022 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (CF) jumped 103.82% in 2021, then tumbled 59.76% in 2022.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $14.0 million in 2021, then slumped by 39.52% to $8.5 million in 2022, then plunged by 35.15% to $5.5 million in 2023, then plunged by 30.7% to $3.8 million in 2024, then rose by 7.17% to $4.1 million in 2025.
- Business Quant data shows ACB's Depreciation & Amortization (CF) at $4.1 million in Q1 2025, $3.8 million in Q4 2024, and $3.8 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 21.95 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 497,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.07 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 3.80 Mn |
| Dec 31, 2024 | 3.80 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 7.34 Mn |
| Mar 31, 2024 | 7.34 Mn |
| Dec 31, 2023 | 5.48 Mn |
| Dec 31, 2023 | 5.48 Mn |
| Sep 30, 2023 | 5.41 Mn |
| Sep 30, 2023 | 5.41 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Sep 30, 2022 | 7.16 Mn |
| Sep 30, 2022 | 7.16 Mn |
| Jun 30, 2022 | 9.91 Mn |
| Jun 30, 2022 | 9.91 Mn |